Platelet Component Bacterial Risk Control: An Evolution in Progress
Runtime: ~25 minutes
Part 1 of 3 – AABB Science and Innovation Forum: Mitigating Bacterial Risk in Platelets: Blood Center and Transfusion Services Perspectives from University of Utah & Stanford
As the October 2021 deadline approaches to implement the FDA’s bacterial risk mitigation guidance, blood centers and hospitals have been evaluating how to ensure a safe and available platelet supply.
In this webinar, University of Utah Health presents its approach to mitigating bacterial risk in platelets with pathogen reduction and testing. A simulation model that compares the bacterial safety of different FDA Guidance testing strategies is also discussed.
Ryan A. Metcalf, MD, CQA(ASQ)
Medical Director, Transfusion Service
Assistant Professor, Inpatient Chief Value Officer, Department of Pathology
University of Utah Health and ARUP Laboratories
Dr. Metcalf completed a residency in Anatomic and Clinical Pathology and a fellowship in Transfusion Medicine at Stanford University. His specific interest is in data-driven approaches to improve understanding of transfusion reactions, patient blood management, and innovation. Dr. Metcalf is a member of the AABB Clinical Transfusion Medicine Committee, the AABB Patient Blood Management Standards Committee, and the College of American Pathologists (CAP) Transfusion, Apheresis, and Cellular Therapy Committee.